EFF defended the free speech and fair use rights of an online newsletter publisher after the world's third largest pharmaceutical company that accused him of trademark infringement and cybersquatting. Since March 2004, AcompliaReport.com has published original news and commentary about clinical trials of Acomplia, a new medication. Drug maker Sanofi-Aventis...